Trial intelligence / Profile preview

Switching Risperidone to Aripiprazole in Early Schizophrenia

NCT00352339Phase 4Unknown

Sponsor
Inje University
Start
Aug 2006
Primary completion
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aripiprazole in schizophrenia, sponsored by Inje University. Status: unknown.

02

Drugs

aripiprazole
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT00352339.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00352339.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call